14 Patents
- US126007102026Beta-catenin and B-cell Lymphoma 9 (BCL9) Inhibitors
LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.
0 cites - 0 cites
- US125655232026Structure-guided Engineering of Peptide-based NLRP3 Inflammasome Inhibitors for Myelodysplastic Syndromes (MDS)
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.
0 cites - US124158322025B-catenin/b-cell Lymphoma 9 Protein-protein Interaction Inhibiting Peptidomimetics
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE Inc.
0 cites - US123196852025Small Molecule Pyrin-domain Targeted NLRP3 Inflammasome Inhibitors
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.
0 cites - US122864222025Methods and Compositions of 4-substituted Benzoylpiperazine-1-substituted Carbonyls as Β-catenin/b-cell Lymphoma 9 Inhibitors
University Of Utah Research Foundation
0 cites - US122698992025Peptidomimetic Inhibitors of Β-catenin/tcf Protein-protein Interaction
H. Lee Moffitt Cancer Center And Research Institute, Inc.
0 cites - 0 cites
- US121628562024Β-catenin and B-cell Lymphoma 9 (BCL9) Inhibitors
H. Lee Moffitt Cancer Center And Research Institute, Inc.
0 cites - 0 cites
- US119052732024Inhibitors for the B-catenin/b-cell Lymphoma 9 (BCL9) Protein-protein Interaction
H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, Inc.
0 cites - 0 cites
- US115422502023Inhibitors for the B-catenin/b-cell Lymphoma 9 (BCL9) Protein-protein Interaction
H. Lee Moffitt Cancer Center And Research Institute, Inc.
0 cites - US115422542023Methods and Composition of 4-substituted Benzoylpiperazine-1-substituted Carbonyls as Beta-catenin/b-cell Lymphoma 9 Inhibitors
UNIVERSISITY OF UTAH RESEARCH FOUNDATION
0 cites